Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™ in Patients With Drug Susceptible Tuberculosis

NCT04249531 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04249531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™ in Patients With Drug Susceptible Tuberculosis
Lead sponsor
University Medical Center Groningen
Phase
Phase 1
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 1, 2022
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis